Skip to content

RTLC: sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

RTLC

BE 0840.135.311
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE division 21, Manufacture of basic pharmaceutical products and pharmaceutical preparations all sizesfiscal years 2021 to 2025145 to 173 sector peers per ratio

Summary

fiscal year 2025

RTLC does better than half of its sector on 4 of the 6 ratios compared.

most favourable quarter above the median below the median least favourable quarter
Strongest points
  • Working-capital ratiobetter than 81%
  • Current ratiobetter than 69%
  • Solvencybetter than 68%
Points to watch
  • Return on equitybetter than 27%
  • Return on assetsbetter than 35%

Solvency and debt

How soundly the company is financed.
Solvency
61.9%▲2025

Solvency is above 68% of 171 sector peers: more favourable than the median.

Position against the sector stable since 2021.

20212022202320242025
Debt to equity
0.62▼2025

Debt to equity is below 51% of 169 sector peers: more favourable than the median.

Position against the sector stable since 2021.

20212022202320242025

Liquidity

Whether it can pay its short-term bills.
Current ratio
2.62▲2025

The current ratio is above 69% of 170 sector peers: more favourable than the median.

Position against the sector improving since 2021.

20212022202320242025
Working-capital ratio
61.9%▲2025

The working-capital ratio is above 81% of 171 sector peers: in the most favourable quarter.

Position against the sector stable since 2021.

20212022202320242025

Profitability

What the company earns on its assets and its sales.
Return on equity
-1.2%▼2025

Return on equity is below 73% of 145 sector peers: less favourable than the median.

Position against the sector weakening since 2021.

20212022202320242025
Return on assets
-0.7%▼2025

Return on assets is below 65% of 173 sector peers: less favourable than the median.

Position against the sector weakening since 2021.

20212022202320242025

Not computable

Long-term debt ratio, Interest coverage, Net margin, EBITDA margin, Gross margin, Days sales outstanding, Days payable outstanding, Days inventory. This company files the abbreviated or micro schema, in which turnover and purchases are optional; margins and credit terms therefore cannot be taken from its figures.

Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 29 September 2026 via checked.be.